BlackRock Investment Management, LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 38 filers reported holding PSYCHEMEDICS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q4 2016$22,000
+29.4%
8770.0%0.00%
Q3 2016$17,000
+41.7%
8770.0%0.00%
Q2 2016$12,000
-7.7%
877
-8.5%
0.00%
Q1 2016$13,000
+30.0%
9580.0%0.00%
Q4 2015$10,000
+11.1%
958
+9.6%
0.00%
Q3 2015$9,000
-30.8%
8740.0%0.00%
Q2 2015$13,000
-13.3%
874
-4.9%
0.00%
Q1 2015$15,000
+7.1%
9190.0%0.00%
Q4 2014$14,000
+7.7%
9190.0%0.00%
Q3 2014$13,0000.0%9190.0%0.00%
Q2 2014$13,0009190.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
22NW, LP 274,418$1,089,4390.78%
WEALTH EFFECTS LLC 40,701$161,5820.08%
Cannell Capital 74,794$296,9320.07%
SANTA MONICA PARTNERS LP 20,000$790.06%
RBF Capital, LLC 144,231$572,5970.04%
WEDBUSH SECURITIES INC 42,414$1680.01%
Ancora Advisors LLC 78,373$311,1410.01%
Your Advocates Ltd., LLP 1,400$5,5580.00%
CRAWFORD INVESTMENT COUNSEL INC 32,098$127,4280.00%
Renaissance Technologies 273,663$1,0860.00%
View complete list of PSYCHEMEDICS CORP shareholders